This is a StreetInsider.com Premium Only Page

(ELDN) – StreetInsider.com Reports

Mar 28, 2024 05:12 PM Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c

Mar 21, 2024 10:31 AM Eledon Pharmaceuticals (ELDN) Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human

Jan 4, 2024 04:43 PM Eledon Pharmaceuticals (ELDN) Highlights Recent Business Milestones, Provides 2024 Outlook

Nov 9, 2023 06:25 PM Eledon Pharmaceuticals, Inc. (ELDN) Tops Q3 EPS by 8c

Nov 2, 2023 09:06 AM Eledon Pharmaceuticals (ELDN) Reports Updated Data from Ongoing Phase 1b Trial of Tegoprubart

Oct 24, 2023 06:36 AM Eledon Pharamceuticals (ELDN) PT Lowered to $13 at H.C. Wainwright

Oct 23, 2023 07:01 AM Eledon Pharmaceuticals (ELDN) Appoints Eliezer Katz as Chief Medical Officer

Oct 2, 2023 07:07 AM Eledon Pharmaceuticals (ELDN) Appoints Kidney Transplant Specialist Dr. Allan Douglas Kirk to Board of Directors

Sep 27, 2023 07:36 AM Noble Capital Starts Eledon Pharamceuticals (ELDN) at Outperform

Sep 25, 2023 07:03 AM Eledon Pharmaceuticals (ELDN) Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

Sep 11, 2023 07:02 AM Eledon Pharmaceuticals (ELDN) Appoints James Robinson to its Board

May 19, 2023 04:18 AM Eledon Pharmaceuticals (ELDN) Announces 75.76M Share Offering by Selling Stockholders

May 11, 2023 04:41 PM Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 15c

May 1, 2023 07:03 AM Eledon Pharmaceuticals (ELDN) Announces up to $185M Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials

May 1, 2023 07:02 AM Eledon Pharmaceuticals (ELDN) Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials

Mar 31, 2023 06:01 AM Eledon Pharmaceuticals (ELDN) Reports Data from Ongoing Phase 1b Trial of Tegoprubart

Mar 23, 2023 08:03 AM Eledon Pharmaceuticals (ELDN) to Present Data from Ongoing Phase 1b Trial of Tegoprubart

Feb 23, 2023 06:33 AM Eledon Pharamceuticals (ELDN) PT Lowered to $9 at Cantor Fitzgerald

Sep 7, 2022 09:19 AM Pre-Open Movers: UiPath Sinks Following Results, Coupa Software Gains

Sep 6, 2022 05:34 PM After-Hours Movers: Coupa Software Jumps on Strong EPS, UiPath Falls

Sep 6, 2022 04:03 PM Eledon Pharmaceuticals (ELDN) Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy

Aug 1, 2022 05:49 AM Eledon Pharmaceuticals (ELDN) Granted FDA Clearance of IND Application to Evaluate Tegoprubart

Jun 9, 2022 08:03 AM Eledon Pharmaceuticals (ELDN) Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation

May 31, 2022 06:09 AM Eledon Pharmaceuticals (ELDN) Reports Phase 2a Trial of Tegoprubart Demonstrating Safety, Target Engagement, and Biomarker Response in Patients Living with Amyotrophic Lateral Sclerosis

May 13, 2022 08:27 AM Cantor Fitzgerald Assumes Eledon Pharamceuticals (ELDN) at Overweight

Feb 14, 2022 08:03 AM Eledon Pharmaceuticals (ELDN) Provides 2022 Outlook

Jul 21, 2021 06:33 AM Companies with NDRs 7/21

Jul 2, 2021 08:02 AM Eledon Pharmaceuticals (ELDN) Appoints Jan Hillson to its Board

Apr 27, 2021 06:42 AM Eledon Pharamceuticals (ELDN) PT Lowered to $39 at Ladenburg Thalmann

Apr 26, 2021 04:26 PM Eledon Pharmaceuticals (ELDN) says FDA requests it provide AT-1501 specific, renal transplant data in non-human primates prior to initiating a Phase 2 trial in renal transplantation in the United Stat

Mar 23, 2021 09:28 AM Pre-Open Movers 03/23: (ORMP) (TKAT) (BLFS) Higher; (FREQ) (ANIX) (IONX) Lower (more...)

Mar 22, 2021 05:44 PM After-Hours Stock Movers 03/22: (BLFS) (CHMA) (PTGX) Higher; (IONS) (RAVN) (QS) Lower (more...)

Mar 22, 2021 04:34 PM Cantor Fitzgerald Starts Eledon Pharamceuticals (ELDN) at Overweight

Feb 8, 2021 08:12 AM SVB Leerink Starts Eledon Pharamceuticals (ELDN) at Outperform